125 related articles for article (PubMed ID: 38775468)
1. Ursoricin, a bacteriocin of
Wang C; Le MN-T; Kawada-Matsuo M; Hisatsune J; Sugawara Y; Arai C; Nakanishi J; Takeda K; Shiba H; Sugai M; Komatsuzawa H
Appl Environ Microbiol; 2024 Jun; 90(6):e0016224. PubMed ID: 38775468
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
Sharma M; Manhas RK
BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
[TBL] [Abstract][Full Text] [Related]
4. Four Novel Leaderless Bacteriocins, Bacin A1, A2, A3, and A4 Exhibit Potent Antimicrobial and Antibiofilm Activities against Methicillin-Resistant Staphylococcus aureus.
Liu S; Deng S; Liu H; Tang L; Wang M; Xin B; Li F
Microbiol Spectr; 2022 Oct; 10(5):e0094522. PubMed ID: 36000904
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.
Sandiford S; Upton M
Antimicrob Agents Chemother; 2012 Mar; 56(3):1539-47. PubMed ID: 22155816
[TBL] [Abstract][Full Text] [Related]
6. Bringing resistance modulation to methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) strains using a quaternary ammonium compound coupled with zinc oxide nanoparticles.
Eskandari F; Mofidi H; Asheghi B; Mohammadi F; Gholami A
World J Microbiol Biotechnol; 2023 May; 39(7):193. PubMed ID: 37166585
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and risk factors of methicillin-resistant
Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
[TBL] [Abstract][Full Text] [Related]
8. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
[TBL] [Abstract][Full Text] [Related]
9. Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study.
Yoon YK; Lee MJ; Ju Y; Lee SE; Yang KS; Sohn JW; Kim MJ
Ann Clin Microbiol Antimicrob; 2019 Oct; 18(1):28. PubMed ID: 31601221
[TBL] [Abstract][Full Text] [Related]
10. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Constituents from
Muhammad I; Jacob MR; Ibrahim MA; Raman V; Kumarihamy M; Wang M; Al-Adhami T; Hind C; Clifford M; Martin B; Zhao J; Sutton JM; Rahman KM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352963
[TBL] [Abstract][Full Text] [Related]
13. A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms.
Kranjec C; Ovchinnikov KV; Grønseth T; Ebineshan K; Srikantam A; Diep DB
NPJ Biofilms Microbiomes; 2020 Dec; 6(1):58. PubMed ID: 33268776
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
15. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
[TBL] [Abstract][Full Text] [Related]
16. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.
Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D;
J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Bacteriocins Produced by the Hypermucoviscous Klebsiella pneumoniae Species Complex.
Le MN; Nguyen TH; Trinh VM; Nguyen TP; Kawada-Matsuo M; Kayama S; Sugai M; Komatsuzawa H
Microbiol Spectr; 2023 Jun; 11(3):e0086323. PubMed ID: 37154746
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
19. Purified citritin in combination with vancomycin inhibits VRE in vitro and in vivo.
Oliveira KS; Martins Queiroz PR; Marques Fensterseifer IC; Migliolo L; Oliveira AL; Franco OL
Microbiology (Reading); 2017 Nov; 163(11):1525-1531. PubMed ID: 29043959
[TBL] [Abstract][Full Text] [Related]
20. Structure optimizing of flavonoids against both MRSA and VRE.
Wei MZ; Zhu YY; Zu WB; Wang H; Bai LY; Zhou ZS; Zhao YL; Wang ZJ; Luo XD
Eur J Med Chem; 2024 May; 271():116401. PubMed ID: 38640870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
